• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DAAN HCV assay 定量检测丙型肝炎病毒 RNA 的性能评估及其与 COBAS AmpliPrep/COBAS TaqMan HCV Quantitative Test, v2.0 的比较。

Performance evaluation of the DAAN HCV assay for quantification of hepatitis C virus RNA and its comparison with COBAS AmpliPrep/COBAS TaqMan HCV Quantitative Test, v2.0.

机构信息

Department of Laboratory Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

Nanfang college of Sun Yat-sen University, Guangzhou, China.

出版信息

J Clin Lab Anal. 2020 Jul;34(7):e23280. doi: 10.1002/jcla.23280. Epub 2020 Mar 13.

DOI:10.1002/jcla.23280
PMID:32167624
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7370725/
Abstract

BACKGROUND

The Daan HCV RNA quantitative assay was a recently developed kit with high sensitivity for the detection of HCV RNA. We aimed to evaluate the analytical performance of the Daan HCV RNA quantitative assay and compare it with the COBAS AmpliPrep/COBAS TaqMan HCV Quantitative Test, v2.0.

METHOD

WHO HCV RNA standard, NIBSC 06/102 standard, and CLSI EP documents were used to evaluate the precision, accuracy, linearity, anti-interference ability, and cross-reactivity of the Daan HCV RNA quantitative assay. Overall 198 clinical serum specimens were used to make comparison between the Daan HCV RNA quantitative assay and the Roche Cobas test.

RESULTS

The within-run precision (S ), and total precision (S ) for 6.11 log IU/mL, 4.22 log IU/mL, and 2.32 log IU/mL HCV RNA were 0.13 and 0.15, 0.07 and 0.09, and 0.11 and 0.10, respectively. The linear range was 20-10  IU/mL, and the limit of detection was 15 IU/mL. It did not display any interference with commonly encountered conditions and cross-reactivity with some common virus. A good agreement was observed between the Daan HCV RNA quantitative assay and the Roche Cobas test.

CONCLUSION

The Daan HCV RNA quantitative assay has shown satisfactory performances and excellent agreement with COBAS HCV Quantitative Test on clinical specimens with lower cost, which provides an alternative choice for the diagnosis and monitoring of HCV infection in developing countries.

摘要

背景

Daan HCV RNA 定量检测试剂盒是一种新近开发的试剂盒,具有高灵敏度,可用于检测 HCV RNA。我们旨在评估 Daan HCV RNA 定量检测试剂盒的分析性能,并与 COBAS AmpliPrep/COBAS TaqMan HCV 定量检测试剂盒进行比较。

方法

使用世界卫生组织 HCV RNA 标准品、NIBSC 06/102 标准品和 CLSI EP 文件评估 Daan HCV RNA 定量检测试剂盒的精密度、准确性、线性、抗干扰能力和交叉反应性。总共使用 198 份临床血清标本对 Daan HCV RNA 定量检测试剂盒和 Roche Cobas 检测进行比较。

结果

对于 6.11 log IU/mL、4.22 log IU/mL 和 2.32 log IU/mL HCV RNA,批内精密度(S )和总精密度(S )分别为 0.13 和 0.15、0.07 和 0.09,以及 0.11 和 0.10。线性范围为 20-10 IU/mL,检测限为 15 IU/mL。它没有显示出与常见条件的任何干扰,并且与一些常见病毒没有交叉反应。在临床标本中,Daan HCV RNA 定量检测试剂盒与 Roche Cobas 检测试剂盒之间观察到良好的一致性。

结论

在成本更低的情况下,Daan HCV RNA 定量检测试剂盒在临床标本中表现出令人满意的性能和与 COBAS HCV 定量检测试剂盒的良好一致性,为发展中国家 HCV 感染的诊断和监测提供了另一种选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c776/7370725/c7129a867027/JCLA-34-e23280-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c776/7370725/a4c45ff91524/JCLA-34-e23280-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c776/7370725/c7129a867027/JCLA-34-e23280-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c776/7370725/a4c45ff91524/JCLA-34-e23280-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c776/7370725/c7129a867027/JCLA-34-e23280-g002.jpg

相似文献

1
Performance evaluation of the DAAN HCV assay for quantification of hepatitis C virus RNA and its comparison with COBAS AmpliPrep/COBAS TaqMan HCV Quantitative Test, v2.0.DAAN HCV assay 定量检测丙型肝炎病毒 RNA 的性能评估及其与 COBAS AmpliPrep/COBAS TaqMan HCV Quantitative Test, v2.0 的比较。
J Clin Lab Anal. 2020 Jul;34(7):e23280. doi: 10.1002/jcla.23280. Epub 2020 Mar 13.
2
Analytical characteristics and comparative evaluation of Aptima HCV quant Dx assay with the Abbott RealTime HCV assay and Roche COBAS AmpliPrep/COBAS TaqMan HCV quantitative test v2.0.Aptima HCV定量诊断检测与雅培实时HCV检测及罗氏COBAS AmpliPrep/COBAS TaqMan HCV定量检测v2.0的分析特性及比较评估
Virol J. 2017 Apr 4;14(1):66. doi: 10.1186/s12985-017-0727-3.
3
Second-generation Cobas AmpliPrep/Cobas TaqMan HCV quantitative test for viral load monitoring: a novel dual-probe assay design.第二代 Cobas AmpliPrep/Cobas TaqMan HCV 定量检测用于病毒载量监测:一种新型的双重探针检测设计。
J Clin Microbiol. 2013 Feb;51(2):571-7. doi: 10.1128/JCM.01784-12. Epub 2012 Dec 12.
4
Diagnosis and monitoring of HCV infection using the cobas HCV test for use on the cobas 6800/8800 systems.基于 cobas 6800/8800 系统的 cobas HCV 检测用于 HCV 感染的诊断和监测。
J Clin Virol. 2018 May;102:63-69. doi: 10.1016/j.jcv.2018.02.017. Epub 2018 Feb 24.
5
HCV RNA detection in HCV antibody-positive patients with the COBAS AmpliPrep/COBAS TaqMan HCV test, v2.0 in comparison with FDA-approved nucleic acid tests.采用COBAS AmpliPrep/COBAS TaqMan HCV检测试剂v2.0对丙型肝炎病毒抗体阳性患者进行丙型肝炎病毒RNA检测,并与美国食品药品监督管理局批准的核酸检测方法进行比较。
J Clin Virol. 2014 Aug;60(4):336-40. doi: 10.1016/j.jcv.2014.04.018. Epub 2014 May 4.
6
Multicenter Comparison Study of both Analytical and Clinical Performance across Four Roche Hepatitis C Virus RNA Assays Utilizing Different Platforms.利用不同平台的四种罗氏丙型肝炎病毒RNA检测方法的分析性能和临床性能的多中心比较研究。
J Clin Microbiol. 2017 Apr;55(4):1131-1139. doi: 10.1128/JCM.02193-16. Epub 2017 Jan 25.
7
Differences between two real-time PCR-based hepatitis C virus (HCV) assays (RealTime HCV and Cobas AmpliPrep/Cobas TaqMan) and one signal amplification assay (Versant HCV RNA 3.0) for RNA detection and quantification.两种基于实时荧光定量PCR的丙型肝炎病毒(HCV)检测方法(实时HCV检测法和Cobas AmpliPrep/Cobas TaqMan检测法)与一种信号放大检测法(Versant HCV RNA 3.0)在RNA检测和定量方面的差异。
J Clin Microbiol. 2008 Dec;46(12):3880-91. doi: 10.1128/JCM.00755-08. Epub 2008 Sep 17.
8
Fully automated quantification of hepatitis C virus (HCV) RNA in human plasma and human serum by the COBAS AmpliPrep/COBAS TaqMan system.采用COBAS AmpliPrep/COBAS TaqMan系统对人血浆和人血清中的丙型肝炎病毒(HCV)RNA进行全自动定量分析。
J Clin Virol. 2007 Apr;38(4):326-33. doi: 10.1016/j.jcv.2006.12.021. Epub 2007 Mar 6.
9
Differences between quantification of genotype 3 hepatitis C virus RNA by Versions 1.0 and 2.0 of the COBAS AmpliPrep/COBAS TaqMan HCV Test.COBAS AmpliPrep/COBAS TaqMan HCV检测1.0版和2.0版对丙型肝炎病毒3型RNA定量的差异。
Clin Chem Lab Med. 2017 Jun 27;55(7):956-961. doi: 10.1515/cclm-2016-0799.
10
Performance characteristics of a quantitative hepatitis C virus RNA assay using COBAS AmpliPrep total nucleic acid isolation and COBAS taqman hepatitis C virus analyte-specific reagent.使用COBAS AmpliPrep总核酸分离法和COBAS TaqMan丙型肝炎病毒分析物特异性试剂的定量丙型肝炎病毒RNA检测的性能特征
J Mol Diagn. 2008 Mar;10(2):147-53. doi: 10.2353/jmoldx.2008.070108. Epub 2008 Feb 14.

引用本文的文献

1
Analytical performance and standardization of four HCV RNA assays in China: an evaluation of sensitivity, precision, and genotype inclusivity.中国四种丙型肝炎病毒RNA检测方法的分析性能与标准化:敏感性、精密度及基因型包容性评估
Front Microbiol. 2025 Jun 2;16:1594410. doi: 10.3389/fmicb.2025.1594410. eCollection 2025.

本文引用的文献

1
Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist Therapy.在近期有注射吸毒史或正在使用阿片类激动剂治疗的人群中,每日一次和每日两次直接抗病毒治疗丙型肝炎感染的依从性。
Clin Infect Dis. 2020 Oct 23;71(7):e115-e124. doi: 10.1093/cid/ciz1089.
2
Hepatitis C Direct-Acting Antiviral Treatment Selection, Treatment Failure, and Use of Drug-Drug Interactions in a State Medicaid Program.州医疗补助计划中的丙型肝炎直接作用抗病毒治疗选择、治疗失败和药物相互作用的使用。
J Manag Care Spec Pharm. 2019 Nov;25(11):1261-1267. doi: 10.18553/jmcp.2019.25.11.1261.
3
Factors Correlating to the Development of Hepatitis C Virus Infection among Drug Users-Findings from a Systematic Review and Meta-Analysis.
与吸毒者丙型肝炎病毒感染发展相关的因素——系统评价和荟萃分析的结果。
Int J Environ Res Public Health. 2019 Jul 2;16(13):2345. doi: 10.3390/ijerph16132345.
4
Hepatitis C virus cure with direct acting antivirals: Clinical, economic, societal and patient value for China.使用直接作用抗病毒药物治愈丙型肝炎病毒:对中国的临床、经济、社会及患者价值
World J Hepatol. 2019 May 27;11(5):421-441. doi: 10.4254/wjh.v11.i5.421.
5
Analytical and field evaluation of the Biocentric Generic HCV assay on open polyvalent PCR platforms in France and Cambodia.法国和柬埔寨开放多聚酶链反应平台上的 Biocentric 通用 HCV 检测的分析和现场评估。
J Clin Virol. 2018 Nov;108:53-58. doi: 10.1016/j.jcv.2018.09.011. Epub 2018 Sep 17.
6
The road to elimination of hepatitis C: analysis of cures versus new infections in 91 countries.丙型肝炎消除之路:91个国家治愈病例与新感染病例分析
J Virus Erad. 2017 Jul 1;3(3):117-123. doi: 10.1016/S2055-6640(20)30329-0.
7
Evaluation of the COBAS AmpliPrep/COBAS TaqMan HCV Test v2.0 for HCV viral load monitoring using dried blood spot specimens.使用干血斑样本评估COBAS AmpliPrep/COBAS TaqMan HCV检测v2.0用于丙型肝炎病毒载量监测的效果。
J Virol Methods. 2017 Sep;247:77-80. doi: 10.1016/j.jviromet.2017.05.016. Epub 2017 May 30.
8
Comparison of on-treatment HCV RNA during direct antiviral therapy using two different COBAS TaqMan HCV assays.使用两种不同的COBAS TaqMan HCV检测方法在直接抗病毒治疗期间对治疗中的丙型肝炎病毒RNA进行比较。
J Clin Virol. 2017 Apr;89:51-56. doi: 10.1016/j.jcv.2017.02.008. Epub 2017 Feb 24.
9
Detection of HCV genotypes 1b and 2a by a reverse transcription loop-mediated isothermal amplification assay.采用逆转录环介导等温扩增检测法检测 HCV 基因型 1b 和 2a。
J Med Virol. 2017 Jun;89(6):1048-1054. doi: 10.1002/jmv.24747. Epub 2017 Mar 14.
10
EASL Recommendations on Treatment of Hepatitis C 2016.2016年欧洲肝脏研究学会丙型肝炎治疗指南
J Hepatol. 2017 Jan;66(1):153-194. doi: 10.1016/j.jhep.2016.09.001. Epub 2016 Sep 22.